|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 9/50 | |
| C12N 15/57 | |||
| C07K 19/00 | |||
| C12N 15/62 | |||
| A61K 38/48 | |||
| A61P 35/00 |
| (11) | Number of the document | 2350273 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09824219.1 |
| Date of filing the European patent application | 2009-11-02 | |
| (97) | Date of publication of the European application | 2011-08-03 |
| (45) | Date of publication and mention of the grant of the patent | 2016-04-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/062969 |
| Date | 2009-11-02 |
| (87) | Number | WO 2010/051533 |
| Date | 2010-05-06 |
| (30) | Number | Date | Country code |
| 110218 P | 2008-10-31 | US |
| (72) |
GEORGIOU, George, US
STONE, Everett, US
|
| (73) |
AERase, Inc.,
901 S. MoPac Expressway Barton Plaza One, Suite 250, Austin, TX 78746,
US
|
| (54) | COMPOSITIONS OF ENGINEERED HUMAN ARGINASES AND METHODS FOR TREATING CANCER |
| COMPOSITIONS OF ENGINEERED HUMAN ARGINASES AND METHODS FOR TREATING CANCER |